Rhythm Pharmaceuticals buy Royal Bank of Canada
Start price
06.05.26
/
50%
€81.00
Target price
06.05.27
€116.89
Performance (%)
-5.56%
Price
12.06.26
€74.50
Summary
This prediction is currently active. With a performance of -5.56%, the BUY prediction for Rhythm Pharmaceuticals by Royal_Bank_of_Canada is down slightly. This prediction currently runs until 06.05.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Rhythm Pharmaceuticals | -0.667% | -0.667% |
| iShares Core DAX® | 0.271% | 2.504% |
| iShares Nasdaq 100 | 1.884% | 3.490% |
| iShares Nikkei 225® | 3.579% | 8.127% |
| iShares S&P 500 | 0.151% | 1.918% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals (RYTM) had its price target raised by Royal Bank Of Canada from $136.00 to $137.00. They now have an "outperform" rating on the stock.
Ratings data for RYTM provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€77.50
17.03.26
17.03.26
€113.07
17.03.27
17.03.27
-1.29%
12.06.26
12.06.26
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€84.50
18.02.26
18.02.26
-
18.02.27
18.02.27
-11.83%
12.06.26
12.06.26